• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.

作者信息

Faedda G, Kula N S, Baldessarini R J

机构信息

Department of Psychiatry, Harvard Medical School, Boston, MA 02115.

出版信息

Biochem Pharmacol. 1989 Feb 1;38(3):473-80. doi: 10.1016/0006-2952(89)90387-0.

DOI:10.1016/0006-2952(89)90387-0
PMID:2563653
Abstract

3H-SCH-23390, a selective antagonist of D-1 dopamine (DA) receptors, was used in a radioreceptor assay with rat brain striatal tissue, optimized biochemically, and extensively characterized pharmacologically with striatal membranes. Nonspecific binding, defined with excess cis(Z)-flupenthixol (300 nM), averaged 20-25% of total counts bound. Specific binding was linearly dependent on the amount of original striatal tissue (0-4 mg) or protein (0-250 micrograms), temperature dependent, saturable and reversible, and appeared to involve a single site at ligand concentrations limited to less than 10 nM. Binding in rat brain regions ranked as: striatum greater than accumbens greater than prefrontal cortex greater than posterior cerebral cortex greater than cerebellum. Association was virtually complete within 30 min at 30 degrees, and the rate of dissociation at 30 degrees was 0.0377 min-1 (half-time = 18.4 min). Affinity (Ka or Kd) determined from association and dissociation rate constants and from concentration isotherms averaged 0.349 and 0.340 nM respectively. Including Na+ at 150 mM increased apparent maximum specific binding (Bmax) by 19%, with a 29% increase in affinity; other monovalent cations alone had small effects on specific binding; Ca2+ and Mg2+ reduced binding by 42%. Agents (N = 85) were tested for potency (Ki or IC50) in competition with the ligand (at 0.30 nM). Those known to have selective effects at D-1 receptors, generally, were most potent and stereoselective. Na+ (150 mM) had little effect on the affinity of cis-thioxanthenes but decreased that of most other agents tested with high D-1 affinity. For antipsychotic agents, the correlation of typical clinical daily doses versus Ki at D-1 sites (r = 0.06) was much lower than at D-2 sites (r = 0.94). (-)Thioridazine was discovered to be D-1 selective, whereas the (+) enantiomer was selective for D-2 sites labeled with 3H-spiperone. Relatively sedating antidepressants had greater D-1 affinity than their less-sedating, secondary amine congeners.

摘要

相似文献

1
Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Biochem Pharmacol. 1989 Feb 1;38(3):473-80. doi: 10.1016/0006-2952(89)90387-0.
2
[3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.[3H]SCH 23390可识别大鼠纹状体及其他脑区中的D-1结合位点。
J Pharm Pharmacol. 1986 Dec;38(12):907-12. doi: 10.1111/j.2042-7158.1986.tb03381.x.
3
Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.激动剂和拮抗剂与纹状体D-1多巴胺受体结合的调节:使用选择性D-1拮抗剂[3H]SK&F R-83566的研究
Life Sci. 1986 Jun 9;38(23):2087-96. doi: 10.1016/0024-3205(86)90207-9.
4
Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
Eur J Pharmacol. 1986 Feb 11;121(1):31-8. doi: 10.1016/0014-2999(86)90389-4.
5
Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.大鼠纹状体中选择性D-1受体拮抗剂配体3H-SCH 23390的结合特性研究
Life Sci. 1984 Oct 29;35(18):1885-93. doi: 10.1016/0024-3205(84)90540-x.
6
Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.3H-SCH 23390与多巴胺D-1受体结合的特性。与其他D-1和D-2测量指标的相关性以及选择性损伤的影响。
J Neural Transm. 1987;68(3-4):171-89. doi: 10.1007/BF02098496.
7
Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.视网膜中[3H]SCH 23390的结合位点:特性及其与介导腺苷酸环化酶刺激的多巴胺D1受体的可能关系。
Brain Res. 1986 Dec;387(3):261-70. doi: 10.1016/0169-328x(86)90032-x.
8
Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.牛纹状体膜中多巴胺D1受体的增溶与复性:激动剂和拮抗剂预处理的影响
Neurochem Res. 1990 Jun;15(6):647-57. doi: 10.1007/BF00973757.
9
Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.新型多巴胺能激动剂放射性配体[3H] - 非诺多泮(SKF 82526)与大鼠纹状体中D - 1受体的结合。
Life Sci. 1985 Apr 15;36(15):1427-36. doi: 10.1016/0024-3205(85)90049-9.
10
Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.R-SK与F 38393对纹状体D1和D2多巴胺受体的[3H]匹莫齐特结合而非[3H]螺哌隆结合的选择性和立体特异性相互作用:与SCH 23390的比较。
Eur J Pharmacol. 1984 Mar 2;98(3-4):433-6. doi: 10.1016/0014-2999(84)90294-2.

引用本文的文献

1
Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats.大鼠急性和慢性不可预测应激模型中中枢多巴胺能系统的差异反应。
Neurochem Res. 2010 Jan;35(1):22-32. doi: 10.1007/s11064-009-0026-5. Epub 2009 Jul 1.
2
Kinetics and pharmacology of the D1- and D2-like dopamine receptors in Japanese quail brain.日本鹌鹑脑中D1样和D2样多巴胺受体的动力学与药理学
Cell Mol Neurobiol. 2009 Sep;29(6-7):961-70. doi: 10.1007/s10571-009-9382-6. Epub 2009 Mar 28.
3
Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants.
三环类抗抑郁药对突触后神经元胺摄取(转运-P)的结合与竞争性抑制作用。
Br J Pharmacol. 1996 Mar;117(5):811-6. doi: 10.1111/j.1476-5381.1996.tb15265.x.
4
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function.大鼠纹状体中的D1受体结合:受多种D1和D2拮抗剂影响,但不受盐酸西布曲明、抗抑郁药或增强中枢多巴胺能功能的治疗影响。
J Neural Transm Gen Sect. 1995;102(1):35-46. doi: 10.1007/BF01276563.
5
Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):539-46. doi: 10.1007/BF00169043.
6
Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro.伏隔核中电诱发多巴胺释放的突触前调节:一项体外快速循环伏安法的药理学研究
Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):260-5. doi: 10.1007/BF00251124.